USD 1.35
(4.65%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -5.73 Million USD | 78.71% |
2022 | 8.33 Million USD | -173.39% |
2021 | -10.19 Million USD | -15.61% |
2020 | -661.21 Thousand USD | 71.49% |
2019 | -31.61 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -323 Thousand USD | 78.36% |
2024 Q1 | -1.41 Million USD | -418.9% |
2023 Q1 | -4.75 Million USD | 12.91% |
2023 FY | - USD | 78.71% |
2023 Q3 | -1.22 Million USD | -145.6% |
2023 Q2 | -500 Thousand USD | 89.49% |
2023 Q4 | 412 Thousand USD | 133.55% |
2022 Q1 | 3 Million USD | 166.86% |
2022 Q4 | -5.46 Million USD | 8.65% |
2022 Q3 | -5.97 Million USD | 32.25% |
2022 FY | - USD | -173.39% |
2022 Q2 | -8.82 Million USD | -393.74% |
2021 FY | - USD | -15.61% |
2021 Q4 | -4.49 Million USD | -25.61% |
2021 Q3 | -3.57 Million USD | -211.04% |
2021 Q2 | -1.15 Million USD | -13.41% |
2021 Q1 | -1.01 Million USD | -3.68% |
2020 Q4 | -978 Thousand USD | -538.26% |
2020 Q3 | -153.23 Thousand USD | -3.02% |
2020 Q1 | 376.33 Thousand USD | 0.0% |
2020 Q2 | -148.73 Thousand USD | -139.52% |
2020 FY | - USD | 71.49% |
2019 Q3 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
CannBioRx Life Sciences Corp. | -22.13 Million USD | 74.094% |
BIMI International Medical Inc. | -15.33 Million USD | 62.617% |
China Jo-Jo Drugstores, Inc. | 1.22 Million USD | 567.378% |
Harrow Health, Inc. 8.625% Senior Notes due 2026 | 9.72 Million USD | 158.974% |
Harrow Health, Inc. 11.875% Senior Notes due 2027 | 9.72 Million USD | 158.974% |
Leafly Holdings, Inc. | -5.73 Million USD | -0.0% |
LifeMD, Inc. | -8.21 Million USD | 30.194% |
LifeMD, Inc. | -8.21 Million USD | 30.194% |
TRxADE HEALTH, Inc. | -13.72 Million USD | 58.209% |
PetMed Express, Inc. | -394 Thousand USD | -1355.33% |
Walgreens Boots Alliance, Inc. | -11.27 Billion USD | 99.949% |